Hosted on MSN

Alpha Tau and GE HealthCare mark breakthroughs in radiation therapy

Trial milestone reached: Alpha Tau completed enrolment of 88 patients in its US ReSTART trial for recurrent skin cancer, a key step toward possible FDA pre-market approval. New planning technology: GE ...
Santé log

Alpha Tau to Host Conference Call to Discuss Interim Results from First Three Patients Treated for Recurrent Glioblastoma

An archived webcast will be available following the event.
iaea.org

What is Radiation?

Radiation is energy that moves from one place to another in a form that can be described as waves or particles. We are exposed to radiation in our everyday life. Some of the most familiar sources of ...
Santé log

Alpha Tau Announces 100% Local Disease Control Rate and Favorable Safety Profile Observed in Alpha DaRT® Pancreatic Cancer Trials Presented at DDW 2026

Founded in 2016, Alpha Tau is an Israeli oncology therapeutics company that focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors. The ...
The Manila Times

Alpha Tau Successfully Treats First Pancreatic Cancer Patient in Italy with Alpha DaRT® at the University of Verona’s Pancreas Institute

First patient ever treated with Alpha DaRT for pancreatic cancer in Italy, under a clinical study conducted at the world-renowned Pancreas Institute of the University of VeronaThe study is the first ...